Dashboard
Manage Tickers

CALCCalciMedica, Inc.

Nasdaq calcimedica.com


$ 4.12 $ 0.08 (1.94 %)    

Monday, 26-Aug-2024 15:50:07 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 476.69 $ -0.05 (-0.01 %)
DIA $ 412.95 $ 0.17 (0.04 %)
SPY $ 561.57 $ 0.77 (0.14 %)
TLT $ 97.97 $ -0.17 (-0.17 %)
GLD $ 233.38 $ 0.63 (0.27 %)
$ 4.21
$ 4.45 x 230
-- x --
-- - --
$ 1.75 - $ 8.38
12,055
na
45.26M
$ 1.55
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-12-2024 06-30-2024 10-Q
2 05-13-2024 03-31-2024 10-Q
3 03-28-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-11-2023 06-30-2023 10-Q
6 05-12-2023 03-31-2023 10-Q
7 03-09-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-11-2022 03-31-2022 10-Q
11 03-11-2022 12-31-2021 10-K
12 11-12-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-14-2021 03-31-2021 10-Q
15 03-05-2021 12-31-2020 10-K
16 11-12-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

standard-biotools-and-2-other-penny-stocks-executives-are-buying
Standard BioTools And 2 Other Penny Stocks...
08/28/2024 12:58:54

hc-wainwright--co-reiterates-buy-on-calcimedica-maintains-20-price-target
HC Wainwright & Co. Reiterates Buy on Calc...
08/13/2024 18:05:52

HC Wainwright & Co. analyst Joseph Pantginis reiterates CalciMedica (NASDAQ:CALC) with a Buy and maintains $20 price tar...

calcimedica-q2-2024-adj-eps-036-beats-053-estimate
CalciMedica Q2 2024 Adj EPS $(0.36) Beats ...
08/12/2024 20:14:14

CalciMedica (NASDAQ:CALC) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.53) b...

why-merck-shares-are-trading-lower-by-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Merck Shares Are Trading Lower By 10%?...
07/30/2024 17:53:26

oppenheimer-maintains-outperform-on-calcimedica-raises-price-target-to-20
Oppenheimer Maintains Outperform on CalciM...
07/10/2024 13:52:34

Oppenheimer analyst Leland Gershell maintains CalciMedica (NASDAQ:CALC) with a Outperform and raises the price target from $...

hc-wainwright--co-reiterates-buy-on-calcimedica-maintains-20-price-target
HC Wainwright & Co. Reiterates Buy on Calc...
07/09/2024 15:54:10

HC Wainwright & Co. analyst Joseph Pantginis reiterates CalciMedica (NASDAQ:CALC) with a Buy and maintains $20 price tar...

calcimedica-begins-phase-2-trial-of-auxora-for-acute-kidney-injury-and-respiratory-failure
CalciMedica Begins Phase 2 Trial of Auxora...
07/09/2024 11:42:41

CalciMedica Inc. ("CalciMedica" or the "Company") (NASDAQ:CALC), a clinical-stage biopharmaceutical company foc...

calcimedica-joins-russell-microcap-index
CalciMedica Joins Russell Microcap Index
07/01/2024 12:11:23

hc-wainwright--co-reiterates-buy-on-calcimedica-maintains-20-price-target
HC Wainwright & Co. Reiterates Buy on Calc...
06/27/2024 15:56:01

HC Wainwright & Co. analyst Joseph Pantginis reiterates CalciMedica (NASDAQ:CALC) with a Buy and maintains $20 price tar...

calcimedica-shares-are-trading-higher-after-the-company-announced-topline-data-from-its-phase-2b-carpo-trial-of-auxora-in-acute-pancreatitis
CalciMedica shares are trading higher afte...
06/27/2024 12:18:01

calcimedica-announces-topline-data-from-phase-2b-carpo-trial-of-auxora-in-acute-pancreatitis-primary-objective-of-the-trial-met-with-statistically-significant-dose-response-with-up-to-436-relative-reduction
CalciMedica Announces Topline Data From Ph...
06/27/2024 12:17:28

Primary objective of the trial met with statistically significant dose response with up to 43.6% relative reduction (2.1 day im...

hc-wainwright--co-reiterates-buy-on-calcimedica-maintains-20-price-target
HC Wainwright & Co. Reiterates Buy on Calc...
05/14/2024 11:14:54

HC Wainwright & Co. analyst Joseph Pantginis reiterates CalciMedica (NASDAQ:CALC) with a Buy and maintains $20 price tar...

calcimedica-q1-2024-gaap-eps-001-beats-067-estimate
CalciMedica Q1 2024 GAAP EPS $0.01 Beats $...
05/13/2024 20:19:19

CalciMedica (NASDAQ:CALC) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.67) b...

calcimedica-announces-last-patient-enrolled-in-phase-2b-carpo-trial-of-auxora-in-acute-pancreatitis-full-target-enrollment-of-216-patients-achieved
CalciMedica Announces Last Patient Enrolle...
04/24/2024 12:08:00

Full target enrollment of 216 patients achieved Topline data from CARPO expected in 2Q 2024 LA JOLLA, Calif., April 24, 2024 /P...

calcimedica-and-2-other-penny-stocks-insiders-are-buying
CalciMedica And 2 Other Penny Stocks Insid...
04/03/2024 13:13:02

The Dow Jones index closed lower by around 400 points on Tuesday. When insiders purchase or sell shares, it indicates their con...

oppenheimer-maintains-outperform-on-calcimedica-maintains-14-price-target
Oppenheimer Maintains Outperform on CalciM...
04/01/2024 13:16:21

Oppenheimer analyst Leland Gershell maintains CalciMedica (NASDAQ:CALC) with a Outperform and maintains $14 price target.

hc-wainwright--co-reiterates-buy-on-calcimedica-maintains-20-price-target
HC Wainwright & Co. Reiterates Buy on Calc...
04/01/2024 10:30:48

HC Wainwright & Co. analyst Joseph Pantginis reiterates CalciMedica (NASDAQ:CALC) with a Buy and maintains $20 price tar...

calcimedica-q4-eps-023
CalciMedica Q4 EPS $(0.23)
03/28/2024 12:45:37

CalciMedica (NASDAQ:CALC) reported quarterly losses of $(0.23) per share.

calcimedica-fy23-eps-766-vs-11116-yoy
CalciMedica FY23 EPS $(7.66) Vs $(111.16) YoY
03/28/2024 11:28:52

hc-wainwright--co-reiterates-buy-on-calcimedica-maintains-20-price-target
HC Wainwright & Co. Reiterates Buy on Calc...
03/13/2024 16:39:32

HC Wainwright & Co. analyst Joseph Pantginis reiterates CalciMedica (NASDAQ:CALC) with a Buy and maintains $20 price tar...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION